1-4 of 4
Gunther Gastl, MD
Close
Sort by
Journal Articles

Four Weeks Administration Schedule of Ropeginterferon Alfa-2b (AOP2014/P1101) in Polycythemia Very Patients Allows Maintaining of Efficacy with Favorable Toxicity Profile in the Phase I/II Peginvera Stud

Veronika Buxhofer-Ausch, Heinz Gisslinger, MD, Josef Thaler, MD, Ernst Schlögl, MD, Gunther Gastl, MD Prof, Dominik Wolf, MD, Robert Kralovics, PhD, Bettina Gisslinger, Sarita Ban, MD, Alexander Egle, MD, Thomas Melchardt, MD, Sonja Burgstaller, MD, Ella Willenbacher, MD, Martin Schalling, MSc, Maria Theresa Krauth, MD, Nicole C.C. Them, Michael Zörer, Oliver Ammann-Mwathi, Pavla Kadlecova, Oleh Zagrijtschuk, Christoph Klade, Richard Greil, MD
Journal: Blood
Blood (2015) 126 (23): 1603.
https://doi.org/10.1182/blood.V126.23.1603.1603
Published: 2015
Journal Articles

Impact of Age on Efficacy and Toxicity of Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENEST1st Sub-Analysis

Francis J. Giles, MB, MD FRCPI, FRCPath, Delphine Rea, MD PhD, Michele Baccarani, Nicholas C.P. Cross, PhD, Juan Luis Steegmann, MD, Laimonas Griskevicius, Philipp le Coutre, Daniel Coriu, Ljubomir Petrov, MD PhD, Gert J. Ossenkoppele, MD PhD, Francois-Xavier Mahon, Martin C. Müller, MD, Andrzej Hellmann, MD PhD, Kimmo Porkka, MD PhD, Timothy H. Brümmendorf, Gunther Gastl, MD Prof,, Viviana Tubazio, Angela Pellegrino, Luca Dezzani, Gianantonio Rosti, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2015) 126 (23): 479.
https://doi.org/10.1182/blood.V126.23.479.479
Published: 2015
Journal Articles

Long Term Efficacy and Safety Results and Analysis of Dose Correlations from the Phase I/II Peginvera Study of Ropeginterferon Alfa-2b, a Novel IFNa-2b, in Polycythemia Vera Patient

Heinz Gisslinger, MD, Veronika Buxhofer-Ausch, Josef Thaler, MD, Ernst Schlögl, MD, Gunther Gastl, MD Prof,, Dominik Wolf, MD, Martin Schalling, MSc, Bettina Gisslinger, Sarita Ban, MD, Alexander Egle, MD, Thomas Melchardt, MD, Sonja Burgstaller, MD, Ella Willenbacher, Maria Theresa Krauth, MD, Nicole C.C. Them, Robert Kralovics, PhD, Michael Zörer, Oliver Ammann-Mwathi, Pavla Kadlecova, Oleh Zagrijtschuk, Christoph Klade, Richard Greil, MD
Journal: Blood
Blood (2015) 126 (23): 4056.
https://doi.org/10.1182/blood.V126.23.4056.4056
Published: 2015
Journal Articles

Prospective, Randomized Comparison between Double Transplantation (T) with Melphalan (200 mg/m 2 ) and Triple T with Intermediate Dose Melphalan (100 mg/m 2 ) in Patients with Multiple Myeloma (An Interim Analysis).

Heinz Ludwig, MD, Werner Linkesch, MD, Hedwig Kasparu, MD, Otto Krieger, MD, Ivan Spicka, MD, Gunther Gastl, MD, Richard Greil, MD, Johannes Drach, MD, Josef Thaler, MD, Ingrid Kuhn, Niklas Zojer, MD, Axel Hinke, PhD
Journal: Blood
Blood (2006) 108 (11): 3083.
https://doi.org/10.1182/blood.V108.11.3083.3083
Published: 2006